cutaneous melanoma: A primary melanoma arising from atypical melanocytes in the skin. Precursor lesions include acquired and congenital melanocytic nevi, and dysplastic nevi. Several histologic variants have been recognized, including superficial spreading melanoma, acral lentiginous melanoma, nodular melanoma, and lentigo maligna melanoma.
Melanocytic naevi of ear and external auricular canal
DOID EFO Endpoint Browser PheWeb
CD2_BENIGN_MELANOCYTIC_EAR
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
196 |
4. Check minimum number of eventsNone |
196 |
5. Include endpointsNone |
196 |
6. Filter based on genotype QC (FinnGen only) |
196 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D22
- Name in latin
- Naevus melanocyticus (cutis) auriculae
Similar endpoints
↥List of similar endpoints to
Melanocytic naevi of ear and external auricular canal
based on the number of shared cases.
Similar with more cases:
- Melanocytic naevi of ear and external auricular canal
- Melanocytic naevi
- Melanocytic naevi
- Benign neoplasms
- Benign neoplasms
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 1330 | 810 | 508 |
| Only index persons | 1251 | 778 | 473 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | 0.01 |
| Only index persons | 0.02 | 0.03 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 49.38 | 45.07 | 56.22 |
| Only index persons | 48.91 | 44.97 | 55.38 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 196 | 128 | 68 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 52.02 | 46.05 | 63.26 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 184
- Matched controls
- 1841
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D22.2
ICD-10 Finland
Melanocytic naevi of ear and external auricular canal
+∞
244.7
176
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
10.7
29.7
62
83
DAB00
NOMESCO Finland
Excision of lesion of auricle
42.9
21.4
26
7
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
7.1
17.7
46
82
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
7.4
13.2
32
51
D23.2
ICD-10 Finland
Benign neoplasm: Skin of ear and external auricular canal
32.4
11.8
15
5
S82
ICPC
Naevus/mole
3.8
9.2
41
129
2162A
ICD-9 Finland
Benign neoplasm of skin, Ear and external auditory canal[KORVAN IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]
+∞
8.4
8
*
R23.8
ICD-10 Finland
Other and unspecified skin changes
3.5
8.4
41
139
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
9.1
8.0
16
19
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.2
7.6
23
49
D23.3
ICD-10 Finland
Benign neoplasm: Skin of other and unspecified parts of face
10.0
7.4
14
15
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
8.1
7.1
15
20
DAB10
NOMESCO Finland
Partial excision of auricle
41.6
6.8
8
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.2
6.1
22
57
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
119
686
2.87
11.65
3.0
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
48
189
3.04
9.29
1.8
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
65
3.31
5.23
1.6
1.2
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
24
99
2.62
4.16
3.5
2.9
ng/l
178.8
249.3
0.47
24
88
(4035726)
28
130
2.35
3.80
1.5
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
100
737
1.73
3.49
4.6
6.3
mmol/l
1.2
1.2
0.36
88
638
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
34
185
2.01
3.12
2.8
2.6
%
22.3
21.7
0.11
29
160
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
43
261
1.83
2.86
1.8
2.6
e6/l
0.5
1.0
1.23
25
150
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
83
606
1.64
2.85
2.3
1.9
pmol/l
101.4
93.7
0.70
43
316
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
45
284
1.76
2.63
3.8
3.3
ng/l
90.2
195.2
0.75
31
201
(3024561) Albumin [Mass/volume] in Serum or Plasma
84
627
1.59
2.58
4.4
4.2
g/l
35.7
35.6
0.08
74
591
(4268621)
6
13
4.72
2.29
2.3
1.8
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
8
25
3.29
2.12
1.1
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29
173
1.79
2.04
1.5
2.4
umol/l
7.9
7.3
0.08
22
149
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
83
648
1.49
1.95
2.6
2.3
nmol/l
73.4
77.0
0.55
75
584
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
87
686
1.48
1.95
4.2
5.2
mmol/l
1.2
1.2
0.29
80
629
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
16
3.83
1.95
1.0
1.0
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
141
1229
1.52
1.89
8.0
7.0
u/l
78.2
77.5
0.07
134
1153
(1002224) Polysomnography panel
14
66
2.21
1.87
1.0
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
62
460
1.51
1.85
2.8
3.7
ph
7.4
7.4
—
7
81
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
34
219
1.67
1.84
1.5
2.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
7
23
3.12
1.81
1.1
1.3
—
98.4
—
0
5
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
8
29
2.83
1.81
1.3
1.3
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
6
18
3.40
1.76
1.3
1.1
—
1.2
—
0
5
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
24
2.99
1.74
1.1
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
29
183
1.69
1.69
5.6
7.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
175
1617
1.77
1.69
13.4
13.2
mg/l
22.7
22.7
0.01
140
1254
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
100
830
1.42
1.63
6.2
5.9
umol/l
11.3
11.0
0.13
94
783
(3003740) Influenza virus B Ag [Presence] in Specimen
8
32
2.56
1.61
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
32
2.56
1.61
1.0
1.1
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
54
404
1.46
1.53
3.2
3.1
mg/l
2498.5
242.3
0.69
32
266
(40758558) Short blood count panel - Blood
56
422
1.46
1.53
7.6
6.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
58
441
1.45
1.51
2.4
2.8
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
110
938
1.39
1.48
9.2
8.9
e9/l
4.4
4.1
0.53
94
812
(3020682) Albumin/Creatinine [Ratio] in Urine
55
419
1.43
1.41
3.3
3.8
mg/mmol
4.3
13.2
1.88
32
269
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
9
41
2.25
1.39
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
68
1.98
1.37
1.3
1.9
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
17
2.99
1.36
1.4
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
35
245
1.52
1.36
1.9
2.8
e6/l
3.5
2.9
0.10
16
135
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
66
526
1.38
1.30
2.5
2.8
u/l
23.9
29.5
2.78
58
501
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
18
2.82
1.29
1.0
1.1
—
—
—
0
0
(4306422)
5
18
2.82
1.29
1.4
1.0
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
98
833
1.35
1.29
7.5
5.7
e9/l
0.2
0.2
0.51
89
735
(3052851) Hemolysis interference index of Serum or Plasma
9
44
2.09
1.28
5.4
3.0
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
52
399
1.41
1.27
3.4
3.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
16
94
1.76
1.21
2.8
4.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
8
153
0.50
1.20
3.0
3.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
25
167
1.57
1.19
5.1
6.7
mmol/l
1.8
0.9
0.43
16
130
(3030467) Casts [#/volume] in Urine by Automated count
57
450
1.38
1.18
2.5
2.9
e6/l
0.2
0.4
1.05
45
342
(3009508) Creatinine [Moles/volume] in Urine
57
452
1.37
1.15
2.9
2.9
mmol/l
7.7
7.7
0.03
45
379
(42870588) Differential panel, method unspecified - Blood
64
518
1.35
1.13
5.4
5.0
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
71
584
1.34
1.13
3.0
3.6
e6/l
32.0
76.1
1.51
54
410
(3019198) Lymphocytes [#/volume] in Blood
96
826
1.32
1.11
5.7
5.4
e9/l
2.1
1.9
0.63
86
736
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
66
1.87
1.11
1.9
1.8
—
—
—
0
0
(3019225) pH of Specimen
20
129
1.61
1.10
2.4
4.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
21
2.42
1.09
1.2
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
93
801
1.31
1.06
5.7
5.4
e9/l
0.6
0.6
0.39
82
692
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
11
60
1.88
1.05
1.4
2.4
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
23
156
1.54
1.04
3.4
4.7
ug/l
3.1
36.2
0.66
16
130
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
53
1.93
1.03
1.8
1.7
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
68
1.81
1.03
7.8
8.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
46
577
0.74
1.03
2.3
2.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
30
217
1.45
1.01
1.7
1.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
93
805
1.30
1.01
5.7
5.4
e9/l
0.0
0.0
0.23
82
695
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
23
2.20
0.98
1.2
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
13
77
1.74
0.98
3.2
2.0
u/l
23959.7
7094.7
—
7
26
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
31
0.00
0.97
0.0
1.5
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
137
1253
1.31
0.95
3.6
3.9
pmol/l
14.5
14.6
0.35
125
1141
(3037756) Immunofixation for Serum or Plasma
6
27
2.26
0.94
2.2
1.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
48
382
1.34
0.94
2.7
2.0
mg/l
2.5
3.0
0.63
40
331
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
94
1.65
0.93
1.1
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
66
552
1.29
0.91
8.6
7.3
inr
1.1
1.2
0.82
11
169
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
68
571
1.29
0.91
2.8
3.0
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
47
375
1.33
0.90
1.6
1.5
nmol/l
21.0
21.2
0.02
42
318
(3009542) Hematocrit [Volume Fraction] of Blood
158
1478
1.36
0.90
18.3
13.8
%
40.3
39.9
0.27
115
1127
(3018010) Neutrophils/100 leukocytes in Blood
88
765
1.27
0.90
5.7
5.3
%
56.5
57.3
0.28
82
714
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
10
56
1.83
0.89
1.5
2.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
10
56
1.83
0.89
1.7
2.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
179
1712
1.53
0.88
10.8
9.6
u/l
23.2
24.4
0.60
171
1649
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
125
1136
1.28
0.87
3.2
3.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
18
121
1.54
0.86
3.8
3.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
40
314
1.34
0.86
4.6
4.8
%
22.7
21.9
0.10
14
170
(3002582) Erythrocytes [#/volume] in Urine
59
493
1.28
0.81
2.7
3.0
e6/l
72.4
193.0
0.42
47
381
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
25
0.00
0.79
0.0
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
28
210
1.39
0.79
1.2
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
123
1123
1.26
0.79
4.1
4.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
49
401
1.30
0.79
5.6
5.3
ug/l
1.8
3.1
0.91
42
345
(3002030) Lymphocytes/100 leukocytes in Blood
88
775
1.25
0.78
6.0
5.4
%
29.1
28.2
0.34
82
718
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
0
27
0.00
0.78
0.0
1.7
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
84
736
1.25
0.78
6.1
5.4
%
0.7
0.6
0.14
76
675
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
21
150
1.45
0.77
1.6
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
28
0.00
0.76
0.0
1.5
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
87
767
1.24
0.76
3.4
4.2
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
5
24
2.11
0.75
6.8
2.9
nmol/l
5.6
3.2
—
5
24
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
21
151
1.44
0.75
1.6
1.8
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
5
26
1.95
0.71
1.0
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
5
26
1.95
0.71
2.6
2.7
umol/l
3.6
6.0
—
5
18
(3005033) Fetal Nuchal fold Thickness US
10
61
1.67
0.70
1.3
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
85
753
1.23
0.70
6.1
5.4
%
3.0
2.7
0.63
79
695
(3019069) Monocytes/100 leukocytes in Blood
85
756
1.22
0.66
6.3
5.6
%
8.6
8.5
0.08
79
704
(3047352) Trisomy 18 risk [Likelihood] in Fetus
10
62
1.65
0.66
1.3
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
63
1.62
0.63
1.3
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
30
1.68
0.62
1.2
1.2
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
0
21
0.00
0.60
0.0
1.6
—
15.9
—
0
5
(40768793) Breast Pathology biopsy report
8
52
1.56
0.60
1.3
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
123
1.42
0.60
1.6
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
23
0.00
0.58
0.0
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
45
380
1.24
0.57
1.2
1.2
u/ml
0.7
1.6
—
6
107
(3005322) IgE [Units/volume] in Serum or Plasma
14
100
1.43
0.53
1.3
1.3
u/ml
197.4
126.9
0.32
14
88
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
63
1.45
0.53
1.0
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
175
1693
1.31
0.52
12.8
12.2
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
175
1693
1.31
0.52
16.2
15.0
umol/l
76.4
75.3
0.13
175
1693
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
44
375
1.22
0.51
1.8
2.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
9
65
1.40
0.51
1.8
1.4
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
12
84
1.46
0.50
1.2
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
10
143
0.68
0.49
4.0
3.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
7
45
1.58
0.49
1.0
1.3
ug/g
329.7
325.8
—
7
23
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
48
416
1.20
0.48
4.6
3.2
ng/l
868.6
1278.3
0.77
41
342
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
129
1.35
0.47
1.4
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
163
1569
1.23
0.47
4.2
4.2
mmol/l
4.7
4.7
0.24
151
1460
(3024891) Influenza virus A+B Ag [Presence] in Specimen
7
49
1.44
0.46
1.1
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
60
535
1.18
0.44
3.5
3.0
mmol/l
2.3
2.3
0.15
47
474
(3021601) Nitrite [Presence] in Urine by Test strip
87
800
1.16
0.43
4.5
4.9
estimate
0.0
0.0
—
10
168
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
8
56
1.45
0.43
1.4
2.1
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
11
79
1.42
0.41
1.4
1.5
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
33
1.53
0.41
1.4
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(4062490)
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
0
16
0.00
0.41
0.0
4.4
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
23
187
1.26
0.41
1.8
1.6
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
25
206
1.24
0.40
3.3
2.2
ug/g
78.8
128.6
0.82
20
171
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
71
1.43
0.40
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
71
1.43
0.40
1.3
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
39
447
0.84
0.40
3.6
3.6
estimate
0.0
0.0
0.00
12
163
(3019309) Folate [Moles/volume] in Red Blood Cells
33
282
1.20
0.38
1.6
1.6
nmol/l
1135.5
1146.5
0.03
24
222
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
33
282
1.20
0.38
2.8
2.5
mmol/l
2.4
2.4
0.33
28
251
(3044889) 12 lead EKG panel
114
1075
1.14
0.38
3.7
3.7
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
9
68
1.34
0.38
1.2
1.4
mu/l
257.4
288.6
—
9
62
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
72
1.41
0.37
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
72
1.41
0.37
1.3
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
16
126
1.29
0.36
1.2
1.6
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
5
76
0.65
0.36
2.4
2.6
%
1.2
1.1
—
5
76
(3014576) Chloride [Moles/volume] in Serum or Plasma
22
181
1.24
0.36
5.9
6.3
mmol/l
104.3
104.4
0.05
22
174
(3035350) Ketones [Presence] in Urine by Test strip
87
808
1.14
0.36
3.1
3.5
estimate
0.0
0.0
0.00
12
168
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
6
41
1.48
0.36
1.5
1.5
—
0.1
—
0
11
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
35
303
1.19
0.36
1.9
1.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
209
1.22
0.36
2.1
1.5
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
116
1098
1.14
0.36
3.3
2.9
u/l
39.5
42.5
0.24
107
1043
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
21
253
0.81
0.35
1.3
2.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
97
909
1.13
0.35
4.4
4.3
mmol/l
6.6
6.5
0.28
87
828
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
150
1446
1.16
0.35
5.7
5.3
mmol/mol
38.5
39.3
0.61
140
1354
(3023323) Follitropin [Units/volume] in Serum or Plasma
6
90
0.66
0.33
1.2
1.3
iu/l
20.2
23.3
—
6
77
(3000492) Spirometry study
11
143
0.76
0.33
1.6
1.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
87
812
1.13
0.33
3.1
3.5
estimate
0.0
0.0
0.00
11
161
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
156
1510
1.16
0.33
4.6
4.6
mu/l
2.2
2.6
0.21
142
1382
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
14
110
1.29
0.32
1.4
1.3
—
52.3
—
0
6
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
23
194
1.21
0.31
1.9
1.9
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
53
1.33
0.31
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
53
1.33
0.31
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
53
1.33
0.31
1.4
1.2
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
183
1797
1.28
0.31
22.2
19.4
e9/l
258.2
254.9
0.31
178
1758
(3022621) pH of Urine by Test strip
8
107
0.74
0.30
1.6
2.0
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
7
56
1.26
0.29
1.3
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
164
1598
1.16
0.28
4.9
4.6
mmol/l
2.7
2.8
0.20
152
1479
(3026361) Erythrocytes [#/volume] in Blood
183
1799
1.26
0.28
22.2
19.4
e12/l
4.6
4.5
1.59
178
1754
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
63
1.28
0.28
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
19
159
1.22
0.28
1.4
1.8
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
183
1800
1.25
0.27
22.2
19.4
e9/l
7.0
6.7
1.64
178
1755
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
52
566
0.89
0.27
2.8
4.0
ng/l
20.4
32.1
0.87
31
359
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
52
477
1.12
0.26
2.2
2.4
u/l
59.2
57.4
0.10
46
449
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
12
96
1.27
0.25
1.2
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
96
1.27
0.25
1.2
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
55
508
1.11
0.24
2.1
2.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
51
469
1.12
0.24
2.5
3.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
160
1562
1.13
0.24
4.3
4.2
mmol/l
1.5
1.5
0.02
147
1444
(40760892) CBC W Ordered Manual Differential panel - Blood
40
363
1.13
0.23
4.4
4.9
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
40
1.26
0.22
1.4
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
157
1533
1.12
0.22
4.7
4.2
mmol/l
5.9
5.8
0.60
143
1413
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
11
0.00
0.21
0.0
1.4
—
1.1
—
0
6
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3004451) EKG impression Narrative
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(44813793)
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
10
0.00
0.21
0.0
1.6
—
85.6
—
0
5
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
43
1.17
0.21
1.8
1.3
—
1.9
—
0
5
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
155
0.83
0.21
1.8
1.6
—
—
—
0
0
(4281824)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
0
13
0.00
0.21
0.0
1.8
—
5.0
—
0
6
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
13
0.00
0.21
0.0
3.7
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
9
111
0.80
0.20
1.9
3.2
pmol/l
4.6
4.7
—
9
100
(40768795) Lymph node Pathology biopsy report
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
14
0.00
0.20
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
50
1.21
0.20
1.8
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
20
176
1.15
0.18
4.5
4.6
%
28.8
33.2
1.08
11
111
(3012544) pH of Venous blood
12
142
0.83
0.18
2.2
4.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
7
61
1.15
0.17
3.3
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
67
636
1.08
0.17
3.1
3.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
14
120
1.18
0.17
2.7
2.8
ml/min/173m2
76.8
69.5
—
6
52
(3016879) Cocaine [Presence] in Urine
8
68
1.18
0.17
1.3
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
40
430
0.91
0.16
1.5
1.6
mmol/l
1.3
1.4
0.71
35
372
(3011397) Hemoglobin [Presence] in Urine by Test strip
39
362
1.10
0.16
3.3
3.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
16
182
0.87
0.16
1.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
16
182
0.87
0.16
1.5
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
6
79
0.75
0.16
1.0
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
38
353
1.09
0.15
4.4
1.7
mg/l
1.8
1.1
0.33
30
275
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
7
88
0.79
0.15
1.0
1.0
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
25
274
0.90
0.15
1.5
2.2
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
10
118
0.84
0.14
7.4
4.9
%
0.2
1.0
—
5
43
(3014111) Lactate [Moles/volume] in Serum or Plasma
15
132
1.15
0.13
6.4
5.9
mmol/l
1.5
1.3
0.41
15
126
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
25
229
1.11
0.13
3.0
3.1
ug/l
0.7
0.8
0.23
16
156
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
153
1505
1.08
0.12
3.9
3.7
mmol/l
1.3
1.2
0.59
139
1381
(3022145) Colonoscopy Study observation
22
201
1.11
0.12
1.5
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
13
115
1.14
0.11
2.4
2.0
g/l
10.3
9.9
0.14
13
108
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
44
1.14
0.10
1.8
2.4
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
44
1.14
0.10
1.8
1.3
—
10.1
—
0
10
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.4
1.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
46
1.09
0.09
1.0
1.2
u/l
12.9
9.7
—
5
33
(3021589) Normoblasts [#/volume] in Blood
76
737
1.05
0.09
8.0
8.7
e9/l
0.0
0.0
0.51
61
591
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
32
302
1.07
0.09
1.4
1.7
pmol/l
384.6
453.5
0.99
26
260
(46235355) HIV 1 and 2 tests - Meaningful Use set
36
379
0.94
0.09
2.5
2.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
54
1.11
0.09
1.3
1.5
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
56
1.07
0.08
1.3
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
64
1.10
0.08
1.6
1.6
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
8
74
1.08
0.07
1.3
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
8
75
1.07
0.07
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
48
463
1.05
0.07
1.5
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
14
128
1.10
0.07
6.6
7.4
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
12
131
0.91
0.06
1.3
1.2
iu/ml
120.4
142.9
—
5
59
(3004588) Protein electrophoresis panel - Serum or Plasma
10
90
1.12
0.05
2.1
2.2
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
121
1195
1.03
0.05
3.9
3.7
mm/h
11.7
11.1
0.15
110
1108
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
30
288
1.05
0.05
1.2
1.2
u/ml
0.9
9.3
2.18
12
110
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
153
1518
1.04
0.04
13.1
12.1
ml/min/173m2
84.1
84.4
0.07
123
1227
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
19
180
1.06
0.04
1.2
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
10
109
0.91
0.04
7.4
5.2
%
0.0
0.2
—
5
38
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
31
301
1.04
0.02
1.3
1.2
iu/ml
16.9
38.3
—
9
94
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
33
339
0.97
0.02
1.5
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
34
349
0.97
0.02
1.5
1.4
g/l
2.3
2.3
0.03
18
201
(3002032) Base excess in Venous blood by calculation
13
136
0.95
0.00
2.2
4.1
mmol/l
3.4
1.9
—
7
100
(36660697) Celiac disease serology panel - Serum
15
144
1.05
0.00
1.2
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
49
484
1.02
0.00
3.2
2.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
10
96
1.04
0.00
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
11
106
1.04
0.00
1.1
1.4
—
—
—
0
0
(4010399)
13
129
1.01
0.00
1.2
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
21
211
0.99
0.00
1.7
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
10
103
0.97
0.00
1.8
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
337
1.01
0.00
1.5
1.4
—
—
—
0
0
(3013512) EKG study
41
405
1.02
0.00
2.6
3.9
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
9
91
0.99
0.00
3.4
2.0
nmol/l
14.8
12.9
—
9
83
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
0
8
0.00
0.00
0.0
2.4
—
4.5
—
0
8
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
88.0
—
0
7
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
6.1
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
5.3
—
54.8
—
0
8
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
1789.0
—
0
7
(3024263) Appearance of Synovial fluid
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
37.9
—
0
6
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
5
57
0.87
0.00
3.0
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
67
0.89
0.00
1.3
1.6
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
0
6
0.00
0.00
0.0
11.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
9.1
—
0
5
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3020891) Body temperature
5
57
0.87
0.00
4.4
4.4
—
—
—
0
0
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
85.7
—
0
5
(3000330) Specific gravity of Urine by Test strip
6
69
0.87
0.00
2.2
4.0
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
7
73
0.96
0.00
1.3
1.9
g/l
1.1
1.6
—
7
63
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
17.9
—
0
6
(3034988) Calcium [Moles/volume] in Capillary blood
0
5
0.00
0.00
0.0
1.2
—
1.2
—
0
5
(3020876) Protein [Mass/time] in 24 hour Urine
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
9
0.00
0.00
0.0
2.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
69
0.87
0.00
2.2
2.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
34.6
—
0
5
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
114.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_MELANOCYTIC_EAR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_EAR | 1.145 [0.83, 1.59] | 0.414 |
| Birth year | 0.995 [0.99, 1.0] | 0.269 |
During the follow-up period (1.1.1998 — 31.12.2019), 58 out of 636 females with CD2_BENIGN_MELANOCYTIC_EAR died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_MELANOCYTIC_EAR | 1.019 [0.75, 1.38] | 0.902 |
| Birth year | 0.986 [0.98, 1.0] | 0.004 |
During the follow-up period (1.1.1998 — 31.12.2019), 79 out of 390 males with CD2_BENIGN_MELANOCYTIC_EAR died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_MELANOCYTIC_EAR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.13% | 0.203% |
| 5 | 0.676% | 1.113% |
| 10 | 1.628% | 2.915% |
| 15 | 3.122% | 5.533% |
| 20 | 5.382% | 9.116% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MELANOCYTIC_EAR – Melanocytic naevi of ear and external auricular canal
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data